Year in Review: Psychiatry - MedPage Today

Submitted by Anonymous (not verified) on Tue, 11/27/2018 - 19:00

MedPage TodayYear in Review: PsychiatryMedPage TodayEarlier this year at the American Psychiatric Association (APA) meeting, positive phase III data for the intranasal esketamine spray for depression was reported from two separate trials. The 4-week data clearly demonstrated that the spray, when ...